New app aims to empower young cancer survivors
NCT ID NCT07541183
First seen Apr 24, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This study tests a web app called MyCare eQuoL that helps childhood cancer survivors assess their needs and get personalized support. About 200 survivors aged 16-30 from nine European countries will use the app for six months. The goal is to see if the app helps them feel more in control of their health and improves their quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.
By submitting, you agree to our Terms of use
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MyCare eQuoL web app
What this could lead to
If it works, this could provide a practical tool to help childhood cancer survivors better manage their long-term care and communicate with doctors.
What could go wrong
This is an early-stage study with only 200 participants, so results may not apply to everyone. The app's benefits depend on user engagement and digital literacy.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.